Docebo Inc. (TSX:DCBO)
Canada · Delayed Price · Currency is CAD | Market Cap | 964.85M -13.0% |
| Revenue (ttm) | 367.71M +12.3% |
| Net Income | 47.72M +56.9% |
| EPS | 1.73 +76.0% |
| Shares Out | 24.90M |
| PE Ratio | 20.86 |
| Forward PE | 13.84 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 79,022 |
| Open | 36.23 |
| Previous Close | 36.13 |
| Day's Range | 36.23 - 38.88 |
| 52-Week Range | 19.87 - 40.08 |
| Beta | 0.79 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 6, 2026 |
About Docebo
Docebo Inc. develops and provides learning management platform for training in Canada, the United States, and internationally. The company’s cloud platform consists of a learning suite, which includes Docebo Learn platform, a cloud-based learning platform that allows learning administrators to deliver personalized learning; Docebo Content Marketplace, an access to off-the-shelf learning content and provide predeveloped learning content; Insights module allows organizations to understand the results of learning programs with data visualizations;... [Read more]
Financial Performance
In 2025, Docebo's revenue was $242.69 million, an increase of 11.87% compared to the previous year's $216.93 million. Earnings were $37.51 million, an increase of 40.31%.
Financial numbers in USD Financial StatementsNews
Docebo's 2026 Outlook: AI-Driven Software Platform Scales Capital Efficiency
Docebo has successfully transitioned into a consistently profitable enterprise software provider with strong margins. Growth rates have moderated significantly compared to the company's hyper-growth p...
Docebo Inc (DCBO) Shares Surge 3.4% -- What GF Score of 74 Tells Investors
Docebo Inc (DCBO) Shares Surge 3.4% -- What GF Score of 74 Tells Investors
Docebo announces final results of substantial issuer bid
Docebo (DCBO) will take up and purchase for cancellation 99,332 of its common shares at a purchase price of $25.00 per Common Share under the Company’s substantial issuer bid, for…
Docebo Inc. Announces Final Results of its Substantial Issuer Bid
TORONTO--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) (“Docebo” or the “Company”), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in ...
Docebo announces preliminary results of substantial issuer bid
Docebo (DCBO) announced the preliminary results of its substantial issuer bid to repurchase for cancellation up to $70,000,000 of its outstanding common shares at a price of $25.00 per Common…
Docebo Inc. Announces Preliminary Results of its Substantial Issuer Bid
TORONTO--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) (“Docebo” or the “Company”), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in ...
Docebo Inc (DCBO) Shares Surge 3.7% -- What GF Score of 72 Tells Investors
Docebo Inc (DCBO) Shares Surge 3.7% -- What GF Score of 72 Tells Investors
A Look at Docebo Inc (DCBO) After 5.0% Gain -- GF Value $57.63 vs Price $24.76
A Look at Docebo Inc (DCBO) After 5.0% Gain -- GF Value $57.63 vs Price $24.76
Docebo announces substantial issuer bid price increase, extension
Docebo (DCBO) announced the amendment of the terms of its previously announced substantial issuer bid under which the Company has offered to repurchase from its shareholders for cancellation up to…
Docebo Inc. Announces Substantial Issuer Bid Price Increase and Extension
TORONTO--(BUSINESS WIRE)--Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) (“Docebo” or the “Company”), the Enterprise Platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in ...
Should You Buy Docebo Inc. (DCBO) After Golden Cross?
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
Docebo Targets Government, Healthcare and AI as Enterprise Momentum Builds
Docebo NASDAQ: DCBO is pursuing new growth initiatives across government, skills management, healthcare and artificial intelligence as it continues its shift toward larger enterprise customers, CFO Br...
Docebo Transcript: Oppenheimer 29th Annual Technology, Internet & Communications Conference
The conference highlighted ongoing verticalization into healthcare, strong enterprise and government growth, and successful integration of skills capabilities, driving higher ARR per customer. AI innovation and usage-based monetization are set to accelerate from 2027, while margin expansion and capital allocation focus on buybacks and targeted investments.
Docebo Sees Growth Accelerate as Enterprise, AI and Skills Bets Gain Traction
Docebo NASDAQ: DCBO said its underlying growth accelerated for a second consecutive quarter as the company gains traction with larger enterprise customers, expands its artificial intelligence product ...
A Look at Docebo Inc (DCBO) After 4.1% Decline -- GF Value $56.98 vs Price $22.15
A Look at Docebo Inc (DCBO) After 4.1% Decline -- GF Value $56.98 vs Price $22.15
Docebo Transcript: Canaccord Genuity's 46th Annual Growth Conference
Growth is accelerating, driven by enterprise wins, successful acquisitions, and strong international performance. AI innovation and new product launches are set to enhance customer value, while a targeted push into healthcare and ongoing margin expansion support a positive outlook.
Docebo Q2 Earnings Call Highlights
Docebo NASDAQ: DCBO executives said the company's annual recurring revenue growth re-accelerated for a second consecutive quarter in the second quarter of 2026, supported by enterprise execution, part...
Docebo Earnings Call Transcript: Q2 2026
Second quarter saw accelerating ARR and raised revenue guidance, driven by enterprise and partner strength. Strategic investments in healthcare and AI, along with successful integration of 365Talents, are expanding addressable markets and improving win rates.
Docebo Earnings release: Q2 2026
Docebo released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
Docebo Slides: Q2 2026
Docebo has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 7, 2026.
Docebo MD&A: Q2 2026
Docebo filed a regulatory document on August 7, 2026 disclosing important business information.
Docebo Report: Q2 2026
Docebo published a report on August 7, 2026 containing material business information for investors and shareholders.
Docebo Inc. (DCBO) Beats Q2 Earnings and Revenue Estimates
Docebo (DCBO) delivered earnings and revenue surprises of +59.09% and +1.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Docebo backs FY26 revenue view $274.5M-$276.5M, consensus $275.2M
Backs FY26 adjusted EBITDA view $54.5M-$56.5M. Subscription revenue is expected to be between $255.5M-$257.5M.
Docebo reports Q2 adjusted EPS 37c, consensus 29c
Reports Q2 revenue $68.7M, consensus $68.31M. “Q2 was another milestone quarter for Docebo (DCBO) as disciplined execution and long-term investment continued to strengthen our position with enterprise...